Cargando…
Health care utilization and mortality among elderly patients with myelodysplastic syndromes
Background: Mortality in patients with myelodysplastic syndromes (MDS) is high, and patients are likely to require hospitalizations, emergency department (ED) visits, and transfusions. The relationships between these events and the MDS complications of anemia, neutropenia, and thrombocytopenia are n...
Autores principales: | Lindquist, K. J., Danese, M. D., Mikhael, J., Knopf, K. B., Griffiths, R. I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082156/ https://www.ncbi.nlm.nih.gov/pubmed/21041376 http://dx.doi.org/10.1093/annonc/mdq552 |
Ejemplares similares
-
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
por: Mozessohn, Lee, et al.
Publicado: (2023) -
Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
por: Ritchie, Ellen K
Publicado: (2012) -
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare
por: Griffiths, Robert I., et al.
Publicado: (2012) -
Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes
por: Abou Zahr, Abdallah, et al.
Publicado: (2014) -
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
por: Aanei, Carmen Mariana, et al.
Publicado: (2016)